Machine learning for early screening of influenza A-associated invasive pulmonary aspergillosis in hospitalized patients: a real-world study
Frontiers in Cellular and Infection Microbiology · 09.07.2026 · 16
DOI: 10.3389/fcimb.2026.1896920 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, online erschienen am 09.07.2026. Verfasst von Yiping Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Nanjing Drum Tower Hospital, China Pharmaceutical University, Nanjing, China. Hauptthemen laut MEDLINE: Invasive Pulmonary Aspergillosis, Machine Learning, Influenza, Human, Influenza A virus. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Influenza A-associated invasive pulmonary aspergillosis (IAPA) is a severe fungal complication with high mortality, while early identification remains difficult because of nonspecific clinical manifestations. This study aimed to develop and validate a machine learning (ML) model for early screening of IAPA in hospitalized influenza A patients.
Methods
This retrospective single-center study enrolled 234 hospitalized influenza A patients from January 2023 to December 2025, including 59 patients with IPA. Eligible patients were randomly divided into a training cohort (70%) for model development and a validation cohort (30%) for internal validation. Univariate and multivariate logistic regression analyses were performed to identify independent predictors of IAPA. Five machine learning algorithms, including Logistic Regression (LR), Random Forest (RF), Support Vector Machine (SVM), XGBoost, and LightGBM, were constructed and compared to identify the most clinically applicable model for early screening.
Results
Multivariate logistic regression identified seven independent predictors of IAPA, including smoking history, autoimmune disease, fibrinogen level, lymphocyte count, hemoglobin level, cumulative systemic corticosteroid dose, and corticosteroid treatment course of 8–28 days. Among the evaluated algorithms, LightGBM demonstrated the highest sensitivity (0.76) in the validation cohort and was considered the most suitable model for early screening. The LightGBM model achieved an AUC of 0.800 (95% CI, 0.714–0.886), with a specificity of 0.69 and an accuracy of 0.68.
Conclusion
LightGBM serves as a robust early-warning tool for identifying influenza A patients at high risk of IAPA. Utilizing routinely available clinical data, this model facilitates bedside risk stratification and early diagnostic intervention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacy, Nanjing Drum Tower Hospital, China Pharmaceutical University, Nanjing, China.
- Department of Pharmacy, Nanjing Drum Tower Hospital, Nanjing, China.
- Department of Pharmacy Administration, The People's Hospital of Wu Hai, Wuhai, China.
- Department of Respiratory and Critical Care Medicine, Nanjing Drum Tower Hospital, Nanjing, China.
- Nanjing Drum Tower Hospital, Nanjing Drum Tower Hospital Clinical College, Nanjing University of Chinese Medicine, Nanjing, China.
Zitieren
APA
Wang, Y., Liu, C., Cao, M., Chen, X., Qian, M., Chen, Y., Li, S., Yang, H., & Zhang, J. (2026). Machine learning for early screening of influenza A-associated invasive pulmonary aspergillosis in hospitalized patients: a real-world study. Frontiers in Cellular and Infection Microbiology, 16. https://doi.org/10.3389/fcimb.2026.1896920
Vancouver
Wang Y, Liu C, Cao M, Chen X, Qian M, Chen Y, et al. Machine learning for early screening of influenza A-associated invasive pulmonary aspergillosis in hospitalized patients: a real-world study. Frontiers in Cellular and Infection Microbiology. 2026;16. doi:10.3389/fcimb.2026.1896920
BibTeX
@article{Wang2026,
author = {Wang, Yiping and Liu, Chunxiang and Cao, Min and Chen, Xingkai and Qian, Ming and Chen, Yewei and Li, Shuting and Yang, Hui and Zhang, Jinping},
title = {Machine learning for early screening of influenza A-associated invasive pulmonary aspergillosis in hospitalized patients: a real-world study},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2026},
volume = {16},
doi = {10.3389/fcimb.2026.1896920}
}
EUVIMED